Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,803 | -63,937 | -46,013 | -61,756 | -17,287 |
| Depreciation Amortization | 1,620 | 2,885 | 1,223 | 1,101 | 545 |
| Income taxes - deferred | -1,686 | 982 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,392 | 3,714 | 38 | 3,084 | 1,787 |
| Other Working Capital | -25 | 25,506 | 26,408 | 5,625 | 44 |
| Other Operating Activity | -412 | -40,078 | -36,068 | 19,584 | -5,275 |
| Operating Cash Flow | $-21,914 | $-70,928 | $-54,412 | $-32,362 | $-20,186 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -6,750 | N/A | N/A | N/A |
| PPE Investments | -4,161 | -6,860 | -3,688 | -2,230 | -596 |
| Net Acquisitions | N/A | -3,842 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -750 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -600 | 0 | 0 |
| Investing Cash Flow | $-4,161 | $-17,452 | $-5,038 | $-2,230 | $-596 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 48,320 | N/A | N/A | N/A |
| Debt Repayment | -21,500 | -9,451 | -3,683 | -2,431 | -1,204 |
| Common Stock Issued | 30 | 108,510 | 105,931 | 96,164 | 3,761 |
| Common Stock Repurchased | N/A | -15,639 | -15,639 | N/A | N/A |
| Other Financing Activity | -1,012 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-22,482 | $131,740 | $86,609 | $93,733 | $2,557 |
| Exchange Rate Effect | 78 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 82,398 | 39,038 | 39,038 | 39,038 | 39,038 |
| End Cash Position | 33,919 | 82,398 | 66,197 | 98,179 | 20,813 |
| Net Cash Flow | $-48,479 | $43,360 | $27,159 | $59,141 | $-18,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,914 | -70,928 | -54,412 | -32,362 | -20,186 |
| Capital Expenditure | -4,161 | -6,860 | -3,688 | -2,230 | -596 |
| Free Cash Flow | -26,075 | -77,788 | -58,100 | -34,592 | -20,782 |